We serve Chemical Name:3,4-Dihydroxybenzaldehyde CAS:139-85-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,4-Dihydroxybenzaldehyde
CAS.NO:139-85-5
Synonyms:Benzaldehyde, 3,4-dihydroxy-;1,2-dihydroxy-4-formylbenzene;3,4-Dihydroxy benzaldehyde;4-formyl-1,2-benzenediol;3,4-Dihydroxybenzyl aldehyde;RANCINAMYCIN IV;MFCD00003370;UNII-4PVP2HCH4T;4-formyl-1,2-dihydroxybenzene;EINECS 205-377-7;3,4-Dihydroxybenzaldehyde;Protocatechuic aldehyde;Protocatechualdehyde
Molecular Formula:C7H6O3
Molecular Weight:138.12
HS Code:29124900
Physical and Chemical Properties:
Melting point:150-157 °C(lit.)
Boiling point:295.4±20.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.674
PSA:57.53000
Exact Mass:138.031693
LogP:1.14
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like Benzaldehyde, 3,4-dihydroxy- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Protocatechualdehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Protocatechualdehyde Use and application,1,2-dihydroxy-4-formylbenzene technical grade,usp/ep/jp grade.
Related News: The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 3,4-Dihydroxybenzaldehyde manufacturer Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition. 3,4-Dihydroxybenzaldehyde supplier We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. 3,4-Dihydroxybenzaldehyde vendor Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. 3,4-Dihydroxybenzaldehyde factory “The synergies among our Regulatory, Clinical and Real-World Evidence (RWE) practices and CROS NT’s global biometrics capabilities will enhance Alira Health’s unique ability to serve clients across their solutions lifecycle,” said CEO Gabriele Brambilla in a statement.
